Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

89170

Sigma-Aldrich

Thorium oxide

≥99.0%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
ThO2
CAS Number:
1314-20-1
Molecular Weight:
264.04
EC Number:
215-225-1
MDL number:
MFCD00036277
UNSPSC Code:
12352300
PubChem Substance ID:
57653329

assay

≥99.0%

reaction suitability

reagent type: catalyst
core: thorium

extent of labeling

7.15 kBq/g specific activity

SMILES string

O=[Th]=O

InChI

1S/2O.Th

InChI key

ZCUFMDLYAMJYST-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Warning

Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Other Notes

Sales restrictions may apply
Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

pictograms

Health hazardSkull and crossbones
GHS08,GHS06

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - STOT RE 2

Storage Class

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
251886/1
251886/1V
BCBJ4163V
BCBJ4163

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

[Carcinogenic chemicals and risk of hematopoietic neoplasms].
Masanobu Kobayashi
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2, 39-42 (2012-11-09)
Yoichiro Yamamoto et al.
Health physics, 99(3), 388-393 (2010-08-12)
Irradiation from internally deposited radionuclides induces malignant tumors. Ingested radionuclides accumulate in specific organs, which are irradiated over a lifelong period. Our aim is to elucidate why the development of malignant tumors requires long-term internal exposure, on the order of
Daniel R McAlister et al.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 140, 18-23 (2018-06-25)
This work presents a complete scheme for the selective separation of actinium and radium isotopes from bulk 232Th target material, in a process that may be applied in a separation scheme for the production of 225Ac by proton spallation on
Rakesh K Behera et al.
Journal of physics. Condensed matter : an Institute of Physics journal, 24(21), 215405-215405 (2012-05-12)
Thorium dioxide (ThO(2)) is of great interest to energy research as thorium-based nuclear fuel offers the promise of increased proliferation resistance, longer fuel cycles, higher burn-up and improved wasteform characteristics in the generation of nuclear power. However, understanding of ThO(2)
Yoichiro Yamamoto et al.
Cancer science, 101(2), 336-340 (2009-11-18)
Exposure to internally deposited radionuclides is known to induce malignant tumors of various histological types. Thorotrast, a colloidal suspension of radioactive Thorium dioxide ((232)ThO(2)) that emits alpha-particles, was used as a radiographic contrast during World War II. Thorotrast is known
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service